Paul Song

Company: Genequantum Healthcare

Job title: Chief Scientific Officer

Seminars:

C-Suite Fireside Chat – Strategizing the Search for the Next ADC Target to Dominate the Limelight – Where is the Next Best Target? 9:00 am

Scoping the current state of the ADC landscape to understand the white space in target selection and the gaps to exploit Collaborating to outline the lessons learned from traditional ADC targets, including HER2, to hypothesize the qualities of a successful target Proposing the realistic expectations for ADC target selection in 2025 and earmarking the predicted…Read more

day: Conference Day One

Navigating the Pre-Clinical Toxicity Risk With Novel ADC Targets Through Establishing Pre-Clinical Models With High Translatability 4:00 pm

Curating a pre-clinical model capable of intracellular targeting, as well as, modeling the drug sensitivity of the ADC target Mirroring the complexity of the tumor microenvironment to gain a comprehensive understanding of the biological interactions between payload and target Modeling the disease progression over time to understand the target re-expression or degradation to inform dosing…Read more

day: Conference Day One